Interstitial cystitis treatment
AssigneeIndevus Pharmaceuticals, Inc.
InventorsBobby Sandage, Glenn Cooper
Life of this patent
Estimating the term…
Abstract
An anti-muscarinic agent exemplified by trospium is administered by intravesicular instillation into the bladder and used to treat interstitial cystitis. The instilled medication does not interact systemically with the patient; the localized effect of the medication avoids any question of systemic side effects or untoward reactions with body organs or systems.
Claims20
A method for the treatment or prophylaxis of interstitial cystitis in a subject in need of such treatment or prophylaxis, comprising administering by intravesicular instillation to the subject an amount of an anti-muscarinic agent or pharmaceutically acceptable salt or prodrug thereof, wherein the amount of the anti-muscarinic agent or pharmaceutically acceptable salt or prodrug thereof comprises an interstitial cystitis treatment- or prophylaxis-effective amount of the anti-muscarinic agent.
A kit comprised of:
- an amount of an anti-muscarinic agent in a dosage formulation.
A kit for use in the treatment of interstitial cystitis, comprising:
- a trospium component in a formulation for intravascular instillation;
- a container housing the trospium component during storage and prior to administration;
- and instructions for carrying out drug administration of trospium in a manner effective to treat intravascular instillation.
Dependencies are inferred from the claim text.